Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of FDL169 and FDL176 in Healthy and Cystic Fibrosis Subjects
NCT03756922Phase 2Suspended
- Sponsor
- Flatley Discovery Lab
- Start
- Nov 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FDL169, FDL176 in cystic fibrosis (CF), sponsored by Flatley Discovery Lab. Started Nov 2018; status: suspended.
02
Drugs
FDL169FDL176
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03756922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756922.